Waypoint Bio Raises $20M to Advance AI -Designed Cell Therapies With Clinical Trials in China
Waypoint Bio raised $20 million in Series A funding to advance AI -designed cell therapies for solid tumors, leveraging China's lower-cost clinical ...
Read the original at citybiz ↗
- Topics
- China & GeopoliticsMarkets & InvestmentHealthcare
- Mentions
- China
- Tracked via
- “chinese ai advances”